Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Bitcoin Predicted To Soar Past $35,000 By Summer As Wallets Holding At Least 1 BTC Hits The 1 Million Mark
-
Axonics Increases 11% As Q4 Prel. Revenue Better Than View
-
Bitcoin (BTC/USD) Price Analysis – 6 July 2023
-
Bitcoin’s Fear and Greed Index Stays In “Greed Zone” For 13 Straight Days — Can BTC Sustain The Bull Run?
-
Crypto Analyst Kevin Svenson Foresees Bitcoin Skyrocketing to $70,000